cilomilast has been researched along with awd 12-281 in 4 studies
| Studies (cilomilast) | Trials (cilomilast) | Recent Studies (post-2010) (cilomilast) | Studies (awd 12-281) | Trials (awd 12-281) | Recent Studies (post-2010) (awd 12-281) |
|---|---|---|---|---|---|
| 162 | 13 | 42 | 7 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bäumer, W; Ehinger, AM; Ehinger, B; Gorr, G; Hoppmann, J; Kietzmann, M | 1 |
| Bäumer, W; Ehinger, AM; Gorr, G; Hoppmann, J; Kietzmann, M; Rundfeldt, C | 1 |
| Draheim, R; Egerland, U; Rundfeldt, C | 1 |
| Hanania, NA; Soto, FJ | 1 |
1 review(s) available for cilomilast and awd 12-281
| Article | Year |
|---|---|
Selective phosphodiesterase-4 inhibitors in chronic obstructive lung disease.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Amides; Aminopyridines; Benzamides; Carboxylic Acids; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Cyclopropanes; Humans; Indoles; Inflammation; Lung; Nitriles; Nucleotides, Cyclic; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pulmonary Disease, Chronic Obstructive | 2005 |
3 other study(ies) available for cilomilast and awd 12-281
| Article | Year |
|---|---|
Effects of the phosphodiesterase 4 inhibitors SB 207499 and AWD 12-281 on the inflammatory reaction in a model of allergic dermatitis.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Amides; Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Dermatitis, Allergic Contact; Ear; Edema; Immunoglobulin E; Indoles; Interleukin-1; Interleukin-4; Mice; Mice, Inbred BALB C; Nitriles; Phosphodiesterase Inhibitors; Skin; Time Factors; Toluene 2,4-Diisocyanate | 2002 |
AWD 12-281, a highly selective phosphodiesterase 4 inhibitor, is effective in the prevention and treatment of inflammatory reactions in a model of allergic dermatitis.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Oral; Administration, Topical; Amides; Animals; Bronchodilator Agents; Carboxylic Acids; Cattle; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Cytokines; Dermatitis, Allergic Contact; Disease Models, Animal; Ear; Female; Indoles; Inflammation; Inflammation Mediators; Injections, Intraperitoneal; Mice; Mice, Inbred BALB C; Nitriles; Time Factors; Toluene | 2003 |
Anti-inflammatory potential of the selective phosphodiesterase 4 inhibitor N-(3,5-dichloro-pyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic acid amide (AWD 12-281), in human cell preparations.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Amides; Aminopyridines; Anti-Inflammatory Agents; Benzamides; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Cyclopropanes; Cytokines; Humans; Indoles; Interleukin-2; Interleukin-4; Interleukin-5; Leukocytes, Mononuclear; Nitriles; Phosphodiesterase Inhibitors; Polyps; Tumor Necrosis Factor-alpha | 2004 |